Finance

Beta
Lists
AGMB:NASDAQ
Agomab Therapeutics NV
$13.31
-0.89%
(-0.12) 1D
Jun 26, 12:00:05 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for AGMB...
Open
$12.82
High
$13.52
Low
$12.50
Mkt. cap
655.49M
Avg. vol.
93.16K
Volume
50.80K
52-wk high
$17.45
52-wk low
$8.75
EPS
-$1.46
No. of employees
62
Open
$12.82
High
$13.52
Low
$12.50
Mkt. cap
655.49M
Avg. vol.
93.16K
Volume
50.80K
52-wk high
$17.45
52-wk low
$8.75
EPS
-$1.46
No. of employees
62
News stories
From sources across the web
About Agomab Therapeutics NV
CEO-
Employees62
Founded2017
Headquarters-
SectorPharmaceutical industry
Websiteagomab.com
Analyst ratings
Based on 2 analysts giving stock ratings to AGMB in the past 3 months
Buy
Buy
2
Hold
0
Sell
0
12-month forecast
Based on 2 Wall Street analysts offering 12 month price targets for AGMB in the last 3 months.
Highest
Current $13.31
$35.00 (+162.96%)
Average
$22.78 (+71.15%)
Lowest
$10.55 (-20.74%)
Analyst
Recommendation
Action
Price target
Projected
Date
Patrick Trucchio
H.C. Wainwright
Buy
Initiated
$35.00
+163%
06/22/2026
Judah Frommer
Morgan Stanley
Buy
Maintained
$10.55
-20.7%
05/18/2026
Anupam Rama
J.P. Morgan
Buy
Initiated
$32.00
+140.4%
03/03/2026
Thomas Smith
Leerink Partners
Buy
Initiated
$36.00
+170.5%
03/03/2026
Previous reportsAll values in EUR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in EUR
Dec 2024
Dec 2025
Revenue
-
-
Cost of goods sold
-
-
Cost of revenue
-
-
Research and development expenses
10.73M
13.86M
Total research and development expenses
-
-
Selling, general, and admin expenses
1.47M
3.17M
Operating expense
11.81M
16.53M
Total operating expenses
11.81M
16.53M
Operating income
-11.81M
-16.53M
Other non operating income
-309.00K
-1.54M
EBT including unusual items
-11.73M
-17.40M
EBT excluding unusual items
-11.73M
-17.40M
Income tax expense
4.00K
-
Effective tax rate
-0.03%
-
Other operating expenses
-383.00K
-506.00K
Net income
-11.73M
-17.40M
Net profit margin
-
-
Earnings per share
-
-
Interest and investment income
626.00K
720.00K
Interest expense
-
-
Net interest expenses
626.00K
720.00K
Depreciation and amortization charges
-
-
EBITDA
-11.80M
-16.51M
Gain or loss from assets sale
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
Give me an overview of AGMB
Explore what’s possible
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer